182 related articles for article (PubMed ID: 12760711)
41. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
42. Treatment of Helicobacter pylori.
Bytzer P; O'Morain C
Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
[TBL] [Abstract][Full Text] [Related]
43. Evolution of Helicobacter pylori therapy from a meta-analytical perspective.
Gisbert JP; Pajares R; Pajares JM
Helicobacter; 2007 Nov; 12 Suppl 2():50-8. PubMed ID: 17991177
[TBL] [Abstract][Full Text] [Related]
44. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
45. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
[TBL] [Abstract][Full Text] [Related]
46. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
Gisbert JP; Castro-Fernandez M; Perez-Aisa A; Cosme A; Molina-Infante J; Rodrigo L; Modolell I; Cabriada JL; Gisbert JL; Lamas E; Marcos E; Calvet X
Aliment Pharmacol Ther; 2012 Apr; 35(8):941-7. PubMed ID: 22372560
[TBL] [Abstract][Full Text] [Related]
47. DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Nada T; Ando T; Nobata K; Tsuzuki T; Minami M; Ina K; Iinuma Y; Ichiyama S; Ohta M; El-Omar E; Kusugami K; Goto H
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():39-47. PubMed ID: 15298604
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
49. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
[TBL] [Abstract][Full Text] [Related]
50. Retreatment of Helicobacter pylori infection after initial treatment failure.
Kearney DJ
Am J Gastroenterol; 2001 May; 96(5):1335-9. PubMed ID: 11374665
[TBL] [Abstract][Full Text] [Related]
51. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
Leodolter A; Peitz U; Malfertheiner P
Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori therapy: first-line options and rescue regimen.
Gisbert JP; Pajares JM
Dig Dis; 2001; 19(2):134-43. PubMed ID: 11549823
[TBL] [Abstract][Full Text] [Related]
53. [Peptic ulcer, functional dyspepsia, Helicobacter pylori: a 1998 stock-taking on the topic of their correlation and therapeutic strategies].
Dobrilla G
Recenti Prog Med; 1999 Jun; 90(6):347-54. PubMed ID: 10399477
[TBL] [Abstract][Full Text] [Related]
54. Eradication of Helicobacter pylori: why does it fail?
Deltenre M; Ntounda R; Jonas C; De Koster E
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S326-8. PubMed ID: 10077767
[TBL] [Abstract][Full Text] [Related]
55. [Current perspective of the resistance of Helicobacter pylori strains to antimicrobial drugs].
Lochmannová J
Klin Mikrobiol Infekc Lek; 2010 Dec; 16(6):199-202. PubMed ID: 21243598
[TBL] [Abstract][Full Text] [Related]
56. [Eradication therapy of Helicobacter pylori infection].
Kodama M; Fujioka T
Rinsho Byori; 2001 Feb; 49(2):130-4. PubMed ID: 11307304
[TBL] [Abstract][Full Text] [Related]
57. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori.
Mégraud F
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S49-54. PubMed ID: 8574736
[TBL] [Abstract][Full Text] [Related]
58. How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint.
de Boer WA; Tytgat GN
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):709-16. PubMed ID: 8853263
[TBL] [Abstract][Full Text] [Related]
59. [A strategy for second-line anti-Helicobacter pylori therapy in eradication-failure patients].
Hojo M; Ohkusa T; Miwa H; Sato N
Nihon Rinsho; 2003 Jan; 61(1):113-8. PubMed ID: 12607327
[TBL] [Abstract][Full Text] [Related]
60. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2012 Jan; 35(2):209-21. PubMed ID: 22129228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
